British Journal of Haematology

Papers to be published in forthcoming issues
pp. i-i(1)

Hodgkin's disease of bone marrow masquerading as a heavy plasma cell infiltration and fibrosis
pp. 343-343(1)
Authors: Joshi A.; Aqel N.M.

Neutrophil inclusions in cryoglobulinaemia
pp. 344-344(1)
Authors: Laidlaw S.T.; Wagner B.; Reilly J.T.

Late-effects among survivors of leukaemia and lymphoma during childhood and adolescence
pp. 345-359(15)
Authors: Robison L.L.; Bhatia S.

It's moving day: factors affecting peripheral blood stem mobilization and strategies for improvement
pp. 360-375(16)
Authors: Fruehauf S.; Seggewiss R.

Increased in vitro cellular drug resistance is related to poor outcome in high-risk childhood acute lymphoblastic leukaemia
pp. 376-385(10)
Authors: Frost B-M.; Nygren P.; Gustafsson G.; Forestier E.; Jonsson O.G.; Kanerva J.; Nygaard R.; Schmiegelow K.; Larsson R.; Lönnerholm G.

Once-weekly epoetin beta is highly effective in treating anaemic patients with lymphoproliferative malignancy and defective endogenous erythropoietin production
pp. 386-393(8)
Authors: Cazzola M.; Beguin Y.; Kloczko J.; Spicka I.; Coiffier B.

Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study
pp. 394-403(10)
Authors: Hedenus M.; Adriansson M.; Miguel J.S.; Kramer M.H.H.; Schipperus M.R.; Juvonen E.; Taylor K.; Belch A.; Altés A.; Martinelli G.; Watson D.; Matcham J.; Rossi G.; Littlewood T.J.

Patterns of bone marrow involvement in 58 patients presenting primary splenic marginal zone lymphoma with or without circulating villous lymphocytes
pp. 404-412(9)
Authors: Audouin J.; Le Tourneau A.; Molina T.; Camilleri-Broët S.; Adida C.; Comperat E.; Benattar L.; Delmer A.; Devidas A.; Rio B.; Diebold J.

Impact of granulocyte colony-stimulating factor (CSF) and granulocyte–macrophage CSF in patients with malignant lymphoma: a systematic review
pp. 413-423(11)
Authors: Bohlius J.; Reiser M.; Schwarzer G.; Engert A.

Clinical heterogeneity in chronic myeloid leukaemia reflecting biological diversity in normal persons
pp. 424-429(6)
Authors: Gordon M.Y.; Marley S.B.; Apperley J.F.; Marin D.; Kaeda J.; Szydlo R.; Goldman J.M.

MDS-type abnormalities within myeloma signature karyotype (MM-MDS): only 13% 1-year survival despite tandem transplants
pp. 430-440(11)
Authors: Jacobson J.; Barlogie B.; Shaughnessy J.; Drach J.; Tricot G.; Fassas A.; Zangari M.; Giroux D.; Crowley J.; Hough A.; Sawyer J.

A new staging system for multiple myeloma patients based on the Southwest Oncology Group (SWOG) experience
pp. 441-450(10)
Authors: Jacobson J.L.; Hussein M.A.; Barlogie B.; Durie B.G.M.; Crowley J.J.

Routine blood counts in children with acute lymphoblastic leukaemia after completion of therapy: are they necessary?
pp. 451-453(3)
Authors: Gandhi M.; Rao K.; Chua S.; Saha V.; Lilleyman J.; Shankar A.

Phosphatase and tensin homologue phosphorylation in the C-terminal regulatory domain is frequently observed in acute myeloid leukaemia and associated with poor clinical outcome
pp. 454-456(3)
Authors: Cheong J-W.; Eom J.I.; Maeng H-Y.; Lee S.T.; Hahn J.S.; Ko Y.W.; Min Y.H.

Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphoma
pp. 457-464(8)
Authors: Shimoni A.; Hardan I.; Avigdor A.; Yeshurun M.; Raanani P.; Ben-Bassat I.; Nagler A.

Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women
pp. 465-470(6)
Authors: Tans G.; van Hylckama Vlieg A.; Thomassen M.C.L.G.D.; Curvers J.; Bertina R.M.; Rosing J.; Rosendaal F.R.

Prothrombotic coagulation defects and cardiovascular risk factors in young women with acute myocardial infarction
pp. 471-478(8)
Authors: Tanis B.C.; Bloemenkamp D.G.M.; van den Bosch M.A.A.J.; Kemmeren J.M.; Algra A.; van de Graaf Y.; Rosendaal F.R.

Basic fibroblast growth factor-stimulated ex vivo expansion of haematopoietic progenitor cells from human placental and umbilical cord blood
pp. 479-488(10)
Authors: Kashiwakura I.; Takahashi T.A.

Chelerythrin activates caspase-8, downregulates FLIP long and short, and overcomes resistance to tumour necrosis factor-related apoptosis-inducing ligand in KG1a cells
pp. 489-497(9)
Authors: Platzbecker U.; Ward J.L.; Deeg H.J.

Fidelity and reproducibility of antisense RNA amplification for the study of gene expression in human CD34⁺ haemopoietic stem and progenitor cells
pp. 498-505(8)
Authors: Attia M.A.; Welsh J.P.; Laing K.; Butcher P.D.; Gibson F.M.; Rutherford T.R.

Direct selection of human bone marrow mesenchymal stem cells using an anti-CD49a antibody reveals their CD45^med,low phenotype
pp. 506-517(12)
Authors: Deschaseaux F.; Gindraux F.; Saadi R.; Obert L.; Chalmers D.; Herve P.

Acquired protein s deficiency in thrombotic thrombocytopenic purpura patients receiving solvent/detergent plasma exchange
pp. 518-519(2)
Authors: Murphy K.; O'Brien P.; O'Donnell J.